Michael Rajnik

Prof. Dr. Michael Rajnik

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
JPJohn H Powers
John H Powers
MGM. Lourdes Guerrero
M. Lourdes Guerrero
NLNancy Kline Leidy
Nancy Kline Leidy
MFMary P. Fairchok
Mary P. Fairchok
ARAlice Rosenberg
Alice Rosenberg
GRGuillermo M. Ruiz-Palacios
Guillermo M. Ruiz-Palacios
To develop content validity of a comprehensive patient-reported outcome (PRO) measure following current best scientific methodology to standardize assessment of influenza (flu) symptoms in clinical research. Stage I (Concept Elicitation): 1:1 telephone interviews with influenza-positive adults (≥18 years) in the US and Mexico within 7 days of diagnosis. Participants described symptom type, character, severity, and duration. Content analysis identified themes and developed the draft Flu-PRO instrument. Stage II (Cognitive Interviewing): The Flu-PRO was administered to a unique set of influenza-positive adults within 14 days of diagnosis; telephone interviews addressed completeness, respondent interpretation of items and ease of use. Samples: Stage I: N = 46 adults (16 US, 30 Mexico); mean (SD) age: 38 (19), 39 (14) years; % female: 56 %, 73 %; race: 69 % White, 97 % Mestizo. Stage II: N = 34 adults (12 US, 22 Mexico); age: 37 (14), 39 (11) years; % female: 50 %, 50 %; race: 58 % White, 100 % Mestizo. Symptoms: Symptoms identified by >50 %: coughing, weak or tired, throat symptoms, congestion, headache, weakness, sweating, chills, general discomfort, runny nose, chest (trouble breathing), difficulty sleeping, and body aches or pains. No new content was uncovered during Stage II; participants easily understood the instrument. Results show the 37-item Flu-PRO is a content valid measure of influenza symptoms in adults with a confirmed diagnosis of influenza. Research is underway to evaluate the suitability of the instrument for children and adolescents. This work can form the basis for future quantitative tests of reliability, validity, and responsiveness to evaluate the measurement properties of Flu-PRO for use in clinical trials and epidemiology studies.

17 August 2014 in Current Infectious Disease Reports
Verified
Journal Article
Closed access
PDF file
DADaniel J. Adams
Daniel J. Adams
MRMichael Rajnik
Michael Rajnik

19 November 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KSKyle Sexton
Kyle Sexton
ASApryl Susi
Apryl Susi
ELElizabeth Lee
Elizabeth Lee
EHElizabeth Hisle-Gorman
Elizabeth Hisle-Gorman
MRMichael Rajnik
Michael Rajnik
CNCade M Nylund
Cade M Nylund
The COVID-19 pandemic has drastically impacted administration of healthcare including well-child visits and routine vaccinations. The purpose of this study was to determine the impact of COVID-19 pandemic disruption on childhood health maintenance: well-child visits and scheduled vaccinations. We queried the TRICARE Management Activity’s Military Health System (MHS) database for outpatient well-child visits and vaccinations for all children 0 to 23 months of age eligible for TRICARE healthcare. The median rate of well-child visits, during the COVID-19 period (March 2020–July 2021), was significantly declined for all demographic groups: all ages, parental military ranks, sex, and regions as compared to the pre-COVID-19 period (February 2019–February 2020). Similar to rates of well-child visits, the rate of vaccinations declined during the COVID-19 period as compared to the pre-COVID-19 period for all demographic groups, except children 12–23 months. Rates of well-child visits for military dependent children under 2 years of age were decreased during the 16 month COVID-19 period, with large increases seen in the first 2 months of the pandemic; the consequences of missed well-child visits and vaccination are unknown.

1 April 2016 in Cleveland Clinic Journal of Medicine
Verified
Journal Article
Closed access
MFMichelle S. Flores
Michelle S. Flores
TBTimothy H. Burgess
Timothy H. Burgess
MRMichael Rajnik
Michael Rajnik
The ongoing outbreak of Zika virus infection that began in South America and Central America in 2014 is worrisome because of associations with fetal microcephaly and with Guillain-Barré syndrome. Here we summarize what has happened and what is known so far. As the outbreak continues to evolve, we urge clinicians to watch for updates at cdc.gov.

2 May 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
MPMatthew D Penfold
Matthew D Penfold
SPSarah Prabhakar
Sarah Prabhakar
ASApryl Susi
Apryl Susi
MRMichael Rajnik
Michael Rajnik
CNCade M Nylund
Cade M Nylund
MEMatthew Daniel Eberly
Matthew Daniel Eberly
Background/Objectives: Rotavirus gastroenteritis is a vaccine-preventable disease that leads to hospitalization in children less than 5 years of age. Immunizations to prevent rotavirus have greatly altered the epidemiology of significant diarrheal illness. It has been reported that routine immunization rates in children were impacted during the COVID-19 pandemic. Contrary to this fact, rates of many childhood illnesses also decreased. Methods: The Military Health System Data Repository (MDR) contains the health records of all military beneficiaries. We queried the MDR before and during the COVID-19 pandemic to assess for alterations in immunization rates and hospitalization rates and to assess for risk factors for significant (hospitalizations) rotavirus disease. Results: Our study included a cohort of 1.27 million children under the age of 5 years old. There were 186 unique cases of rotavirus-related hospitalizations over the 5-year study period. During COVID-19 Years 1 and 2, there was a decrease in rotavirus-related hospitalizations compared to the pre-pandemic period. During Year 3, there was a return to the pre-pandemic level of rotavirus hospitalization rates. Patients in the northern United States were less likely to be hospitalized from rotavirus when compared to those in the south. The patients at greatest risk were the youngest beneficiaries. Rotavirus vaccination rates declined in this age group during all three years of the pandemic. Conclusions: As the pandemic resulted in less frequent rotavirus immunizations in the Military Health System (MHS), there was not an increase in rotavirus-related hospitalizations above the pre-pandemic baseline.

3 November 2025 in Advances in Clinical Medical Research and Healthcare Delivery
Verified
Journal Article
Open access
PDF file
AJAli Jaan
Ali Jaan
PSPriyanshi Shah
Priyanshi Shah
ADAshish Dhawan
Ashish Dhawan
SQSaria Qaiser
Saria Qaiser
AAAzka Ali
Azka Ali
MRMichael Rajnik
Michael Rajnik
Introduction: The global impact of Coronavirus Disease 2019 (COVID-19), caused by severe-acute-respiratory-syndrome coronavirus 2 (SARS-CoV-2), has been profound, claiming the lives of more than 3 million individuals within a year and a half. Among the affected population, heightened vulnerability is observed among older and frailer individuals, leading to more severe symptoms and adverse outcomes compared to their younger, non-frail counterparts. This study to analyze the impact of frailty on the outcomes of adult patients admitted with COVID-19. Methods: Using the National Inpatient Sample (NIS) database 2020, we identified adult patients admitted with a principal diagnosis of COVID-19. The patients were then divided into two groups, i.e., frail and non-frail, based on the Hospital Frailty Risk Score (HFRS) cut-off of 5. Using a multivariate regression model, we compared COVID-19 hospitalizations, with frailty status serving as the exposure variable. Statistical analysis was performed using STATA version 14.2. Results: Out of 1,050,045 adult patients hospitalized with COVID-19, 509,915 (48.56%) met the criteria for frailty. Among these frail patients, the majority were white, older females with a high comorbidity burden. Compared to their non-frail counterparts, these frail patients experienced greater odds of mortality (adjusted odds ratio [aOR] 4.00, 95% confidence interval [CI] 3.78–4.23;P. Conclusion: In conclusion, our findings highlight a complex interplay between COVID-19 and frailty, revealing that frailty is associated with increased odds of mortality as well as associated complications. These findings contribute to a deeper understanding of the clinical complexities surrounding COVID-19 in frail patients, necessitating tailored management strategies.